InsiderClue
Insiders · Profile

FRIEDMAN PAUL A

Director at MADRIGAL PHARMACEUTICALS · Director at Incyte · Director at Verastem. Filing since 17 Aug 2007. CIK 0001236927

MDGL MADRIGAL PHARMACEUTICALS, INC. Director · 15 trades INCY Incyte Director · 29 trades VSTM Verastem, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
MDGL MADRIGAL PHARMACEUTICALS, INC.
9 Jan 2026
Director
Sold on a plan
24,800
$12.96M
11.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
10 Dec 2025
Director
Sold on a plan
24,800
$13.69M
11.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
13 Aug 2025
Director
Sold on a plan
129,172
$47.83M
40.8%
MDGL MADRIGAL PHARMACEUTICALS, INC.
12 Aug 2025
Director
Sold on a plan
43,605
$15.51M
18.9%
MDGL MADRIGAL PHARMACEUTICALS, INC.
11 Aug 2025
Director
Sold on a plan
3,203
$1.12M
1.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
18 Jul 2025
Director
Sold on a plan
1,400
$490.04K
0.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
17 Jul 2025
Director
Sold on a plan
2,700
$946.30K
1.4%
MDGL MADRIGAL PHARMACEUTICALS, INC.
16 Jul 2025
Director
Sold on a plan
26,176
$9.25M
12.3%
MDGL MADRIGAL PHARMACEUTICALS, INC.
8 Apr 2024
Director
Sold on a plan
26,270
$6.47M
12.4%
MDGL MADRIGAL PHARMACEUTICALS, INC.
5 Apr 2024
Director
Sold on a plan
27,613
$6.72M
12.9%
MDGL MADRIGAL PHARMACEUTICALS, INC.
4 Apr 2024
Director
Sold on a plan
18,710
$4.55M
9.2%
MDGL MADRIGAL PHARMACEUTICALS, INC.
3 Apr 2024
Director
Sold on a plan
27,407
$6.72M
12.9%
INCY Incyte
6 Aug 2019
Director
Sold, plan not stated
77,934
$6.41M
23.4%
INCY Incyte
2 Aug 2019
Director
Sold, plan not stated
22,066
$1.86M
7.9%
MDGL MADRIGAL PHARMACEUTICALS, INC.
20 Nov 2018
Chief Executive Officer
Bought
4,000
$471.52K
2.5%
MDGL MADRIGAL PHARMACEUTICALS, INC.
19 Nov 2018
Chief Executive Officer
Bought
4,000
$496.00K
2.6%
MDGL MADRIGAL PHARMACEUTICALS, INC.
11 Jun 2018
Chief Executive Officer
Sold, plan not stated
73,526
$21.14M
10.1%
INCY Incyte
16 Nov 2017
Director
Sold, plan not stated
28,507
$3.00M
9.6%
INCY Incyte
17 Mar 2017
Director
Sold, plan not stated
41,693
$6.18M
12.3%
INCY Incyte
16 Mar 2017
Director
Sold, plan not stated
8,307
$1.26M
2.7%
INCY Incyte
23 Feb 2017
Director
Sold, plan not stated
50,000
$6.02M
14.4%
INCY Incyte
18 Nov 2015
Director
Sold, plan not stated
125,000
$14.42M
29.6%
INCY Incyte
17 Nov 2015
Director
Sold, plan not stated
100,000
$11.20M
25.2%
INCY Incyte
27 May 2015
Director
Sold, plan not stated
69,132
$7.44M
18.9%
INCY Incyte
26 May 2015
Director
Sold, plan not stated
127,619
$13.66M
30.0%
INCY Incyte
22 May 2015
Director
Sold, plan not stated
79,592
$8.60M
21.1%
INCY Incyte
21 May 2015
Director
Sold, plan not stated
22,651
$2.47M
7.1%
INCY Incyte
13 Feb 2015
Director
Sold, plan not stated
120,000
$8.92M
28.7%
VSTM Verastem, Inc.
24 Dec 2014
Director
Bought
3,000
$24.93K
opened
INCY Incyte
6 Nov 2014
Director
Sold, plan not stated
185,653
$12.60M
30.8%
INCY Incyte
20 Feb 2014
Director
Sold, plan not stated
33,354
$2.12M
7.4%
INCY Incyte
19 Feb 2014
Director
Sold, plan not stated
40,919
$2.56M
8.9%
INCY Incyte
18 Feb 2014
Director
Sold, plan not stated
720,036
$47.39M
63.3%
INCY Incyte
14 Feb 2014
Director
Sold, plan not stated
10,227
$670.07K
2.4%
INCY Incyte
10 Sep 2013
Chief Executive Officer
Sold, plan not stated
376,789
$14.06M
49.0%
INCY Incyte
7 May 2012
Chief Executive Officer
Sold, plan not stated
225,000
$5.08M
42.1%
INCY Incyte
1 Jul 2010
Chief Executive Officer
Bought
10,000
$104.26K
3.9%
INCY Incyte
9 Mar 2009
Chief Executive Officer
Bought
9,400
$19.74K
3.8%
INCY Incyte
6 Mar 2009
Chief Executive Officer
Bought
10,600
$22.26K
4.5%
INCY Incyte
5 Mar 2009
Chief Executive Officer
Bought
8,840
$19.45K
3.9%
INCY Incyte
3 Mar 2009
Chief Executive Officer
Bought
11,160
$24.55K
5.2%
INCY Incyte
20 Nov 2008
Chief Executive Officer
Bought
13,000
$33.15K
6.4%
INCY Incyte
15 Oct 2008
Chief Executive Officer
Bought
5,300
$24.38K
2.7%
INCY Incyte
14 Oct 2008
Chief Executive Officer
Bought
4,700
$25.13K
2.5%
INCY Incyte
17 Aug 2007
Chief Executive Officer
Bought
16,665
$91.16K
9.5%
45 decisions on file.